$OCUL OCULAR THERAPEUTIX, INC Insider Trading Week 30/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OCULAR THERAPEUTIX, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OCULAR THERAPEUTIX, INC in week 30/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 24,181 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 16,565 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 47,131 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 2,418,191 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 40,268 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 27,584 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 78,483 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,026,825 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 9,159 | 0 | 24,412 | 15.3 K to 24.4 K (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 6,275 | 0 | 16,723 | 10.4 K to 16.7 K (+60.06 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 17,853 | 0 | 47,581 | 29.7 K to 47.6 K (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 915,981 | 0 | 2,441,293 | 1.5 M to 2.4 M (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 15,253 | 0 | 15,253 | 0 to 15.3 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 10,448 | 0 | 10,448 | 0 to 10.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 29,728 | 0 | 29,728 | 0 to 29.7 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,525,312 | 0 | 1,525,312 | 0 to 1.5 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 20,804 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 3,523,039 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 14,372 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 2,433,816 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 9,563 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 1,619,102 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 1,174 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 198,826 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 17,391 | 0 | 17,391 | 0 to 17.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 2,944,993 | 0 | 2,944,993 | 0 to 2.9 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 42,440 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 243,902 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 61,664 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 320,836 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 13.00 | 76,922 | 999,986 | 471,784 | 394.9 K to 471.8 K (+19.48 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 16,075 | 0 | 394,862 | 378.8 K to 394.9 K (+4.24 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 213,915 | 0 | 846,377 | 632.5 K to 846.4 K (+33.82 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 23,357 | 0 | 487,242 | 463.9 K to 487.2 K (+5.04 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 117,243 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 27,144 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Buy | C | 0.00 | 92,570 | 0 | 130,448 | 37.9 K to 130.4 K (+244.39 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Buy | C | 0.00 | 18,939 | 0 | 18,939 | 0 to 18.9 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 20,804 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 3,523,039 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 14,372 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 2,433,816 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 9,563 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 1,619,102 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 1,174 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 198,826 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | C | 0.00 | 17,391 | 0 | 17,391 | 0 to 17.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | C | 0.00 | 2,944,993 | 0 | 2,944,993 | 0 to 2.9 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,172,889 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 680,722 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 493,534 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,172,889 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 680,722 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 493,534 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 32,379 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 18,793 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 13,625 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,140,510 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 661,929 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 479,909 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 6,583 | 85,579 | 71,381 | 64.8 K to 71.4 K (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 231,877 | 3,014,401 | 2,514,226 | 2.3 M to 2.5 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 238,460 | 3,099,980 | 2,585,607 | 2.3 M to 2.6 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 238,460 | 3,099,980 | 2,585,607 | 2.3 M to 2.6 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 64,798 | 0 | 64,798 | 0 to 64.8 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,282,349 | 0 | 2,282,349 | 0 to 2.3 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,347,147 | 0 | 2,347,147 | 0 to 2.3 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,347,147 | 0 | 2,347,147 | 0 to 2.3 M |